|
1) Monroe DM, Key NS. The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking. J Thromb Haemost. 2007; 5: 1097-105
|
|
|
|
2) Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2007; 27: 1687-93
|
|
|
|
|
|
3) Key NS, Slungaard A, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood. 1998; 91: 4216-23
|
|
|
|
|
|
4) Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A. 1999; 96: 2311-5
|
|
|
|
|
|
5) Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation？ Arterioscler Thromb Vasc Biol. 2006; 26: 2594-604
|
|
|
|
|
|
6) Mackman N. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis. 2006; 36: 104-7
|
|
|
|
|
|
7) Giesen PL, Nemerson Y. Tissue factor on the loose. Semin Thromb Hemost. 2000; 26: 379-84
|
|
|
|
|
|
8) Nomura S, Ozaki Y, Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res. 2008; 123: 8-23
|
|
|
|
|
|
9) Falati S, Gross P, Merrill-Skoloff G, et al. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med. 2002; 8: 1175-81
|
|
|
|
|
|
10) Chou J, Mackman N, Merrill-Skoloff G, et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood. 2004; 104: 3190-7
|
|
|
|
|
|
11) Parry GC, Erlich JH, Carmeliet PL, et al. Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest. 1998; 101: 560-9
|
|
|
|
|
|
12) Gross PL, Furie BC, Merrill-Skoloff G, et al. Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J Leukoc Biol. 2005; 78: 1318-26
|
|
|
|
|
|
13) Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor？ Blood. 2003; 102: 449-61
|
|
|
|
|
|
14) Dubois C, Panicot-Dubois L, Merrill-Skoloff G, et al. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood. 2006; 107: 3902-6
|
|
|
|
|
|
15) Dubois C, Panicot-Dubois L, Gainor JF, et al. Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model. J Clin Invest. 2007; 117: 953-60
|
|
|
|
|
|
16) Furie B, Furie BC. Thrombus formation in vivo. J Clin Invest. 2005; 115: 3355-62
|
|
|
|
|
|
17) Hrachovinova I, Cambien B, Hafezi-Moghadam A, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med. 2003; 9: 1020-5
|
|
|
|
|
|
18) Siegel-Axel DI, Gawaz M. Platelets and endothelial cells. Semin Thromb Hemost. 2007; 33: 128-35
|
|
|
|
|
|
19) Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med. 2003; 197: 1585-98
|
|
|
|
|
|
20) Muller I, Klocke A, Alex M, et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. Faseb J. 2003; 17: 476-8
|
|
|
|
|
|
21) Reinhardt C, von Bruhl ML, Manukyan D, et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest. 2008; 118: 1110-22
|
|
|
|
|
|
22) Cho J, Furie BC, Coughlin SR, Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest. 2008; 118: 1123-31
|
|
|
|
|
|
23) Schwertz H, Tolley ND, Foulks JM, et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med. 2006; 203: 2433-40
|
|
|
|
|
|
24) Panes O, Matus V, Saez CG, et al. Human platelets synthesize and express functional tissue factor. Blood. 2007; 109: 5242-50
|
|
|
|
|
|
25) Brogren H, Karlsson L, Andersson M, et al. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood. 2004; 104: 3943-8
|
|
|
|
|
|
26) Weyrich AS, Denis MM, Schwertz H, et al. mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood. 2007; 109: 1975-83
|
|
|
|
|
|
27) Pillitteri D, Bassus S, Boller K, et al. Thrombin-induced interleukin 1beta synthesis in platelet suspensions: impact of contaminating leukocytes. Platelets. 2007; 18: 119-27
|
|
|
|
|
|
28) Denis MM, Tolley ND, Bunting M, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005; 122: 379-91
|
|
|
|
|
|
29) Ohmori T, Mimuro J, Takano K, et al. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ib alpha promoter: in vivo model for platelet-targeting gene therapy. Faseb J. 2006; 20: 1522-4
|
|
|
|
|
|
30) Ohmori T, Ishiwata A, Kashiwakura Y, et al. Phenotypic correction of hemophilia A by ectopic expression of activated factor VII in platelets. Mol Ther. 2008; 16: 1359-65
|
|
|
|
|